Histopathologic grading of ovarian carcinoma: A review and proposal

International Journal of Gynecological Pathology

Volumn 19, Issue 1, 2000, Pages 7-15

  Silverberg, Steven G ^a  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

Carcinoma; Grading; Ovary

Indexed keywords

BREAST CARCINOMA; CANCER GRADING; CANCER INVASION; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0033987126     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-200001000-00003     Document Type: Review

References (29)

1. Silverberg SG. Prognostic significance of pathologie features. Curr Top Palhol 1989;78:85-109.
2. Eltabbakh GH, Belinson JL, Kennedy AW, et al. p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer. Cancer 1997;80:892-8.
3. Gadducci A, Sartori E, Maggino T, et al. Analysis of failures in patients with stage I ovarian cancer: an Italian multicenter study. Int J Gynecol Cancer 1997;7:445-50.
4. Brugghe J, Baak JPA, Wiltshaw E, Brinkhuis M, Meijer GA, Fisher C. Quantitative prognostic features in FIGO I ovarian cancer patients without postoperative treatment. Gynecol Oncol 1998; 68:47-53.
5. Geisler JP, Geisler HE, Wiemann MC, Givens SS, Zhou Z, Miller GA. Nuclear shape: an independent predictor of survival in patients with ovarian cancer. Int J Gynecol Cancer 1998;8:164-7.
6. Reles AE, Gee C, Schellschmidt I, et al. Prognostic significance of DNA content and S-phase fraction in epithelial ovarian carcinomas analyzed by image cytometry. Gynecol-Oncol 1998;71:3-13.
7. Anttila MA, Ji H, Juhola MT, Saarikoski SV, Syrjänen KJ. The prognostic significance of p53 expression quantitated by computerized image analysis in epithelial ovarian cancer. Int J Gynecol Pathol 1999; 18:42-51.
8. Ross JS, Yang F, Kallakury BVS, Sheehan CE, Ambros RA, Muraca PJ. HER-2/neu oncogene amplification by fluorescence in situ hybridization in epithelial tumors of the ovary. Am J Clin Pathol 1999;!11:311-6.
9. Wen WH, Reles A, Runnebaum IB, Sullivan-Halley J, et al. p53 mutations and expression in ovarian cancers: correlation with overall survival. Int J Gynecol Pathol 1999;18:29-41.
10. International Federation of Gynecology and Obstetrics. Classification and staging of malignant tumours in the female pelvis. Acta Obstet Gynecol Scand 1971;50:l-7.
11. Serov SF, Scully RE, Sobin LH, eds. Histological typing of ovarian tumours. In: International Histological Classification of Tumours, No. 9. Geneva: World Health Organization, 1973:17-54.
12. Brugghe J, Baak JPA, Wiltshaw E, Fisher C. Further evaluation of reproducibility and prognostic value of histologie typing and grading in FIGO stage I ovarian cancer patients without systemic locoregional adjuvant treatment. Int J Gynecol Cancer 1995;5: 262-8.
13. Benda JA, Zaino R. GOG Pathology Manual. Buffalo, NY: Gynecologic Oncology Group, 1994.
14. Hernandez E, Bhagavan BS, Parmley TH, Rosenshein NB. Interobserver variability in the interpretation of epithelial ovarian cancer. Gynecol Oncol 1984;17:117-23.
15. Baak JPA, Langley FA, Talerman A, Delemarre JFM. Interpathologist and intrapathologist disagreement in ovarian tumor grading and typing. Anal Quant Cytol Histol 1986;8:354-7.
16. Stalsberg H, Abeler V, Blom GP, Bostad L, Skarland E, Westgaard G. Observer variation in histologie classification of malignant and borderline ovarian tumors. Hum Pathol 1988;19:1030-5.
17. Baak JPA, Wisse-Brekelmans ECM, Langley FA, Talerman A, Delemarre JFM. Morphometric data to FIGO stage and histological type and grade for prognosis of ovarian tumours. J Clin Palhol 1986;39:1340-6.
18. Baak JPA, Chan KK, Stolk JG, Kenemans P. Prognostic factors in borderline and invasive ovarian tumours of the common epithelial type. Palhol Res Pract 1987; 182:755-74.
19. Eichel P, Jakobsen A. A new histologie grading index in ovarian carcinoma. Int J Gynecol Palhol 1989:8:147-55.
20. Scully RE, Young RH, Clement PB. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. In: Atlas of Tumor Pathology, Third Series, Fascicle 23. Washington, DC: Armed Forces Institute of Pathology, 1998:40-1.
21. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Hislopalhology 1991; 19:403-10.
22. Pereira H, Pinder SE, Sibbering DM, et al. Pathological prognostic factors in breast cancer. IV. Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma. Histopathology 1995;27:219-26.
23. Shimizu Y, Kamoi S, Amada S, Hasumi K, Akiyama F, Silverberg SG. Toward the development of a universal grading system for ovarian epithelial carcinoma. I. Prognostic significance of histo-pathologie features-Problems involved in the architectural grading system. Gynecol Oncol 1998;70:2-12.
24. Silverberg SG. Reproducibility of the mitosis count in the histologie diagnosis of smooth muscle tumors of the uterus. Hum Palhol 1976;7:451-1
25. Kempson RL, Hendrickson MR. Mesenchymal neoplasms of the uterus. In: Fox H, ed. Obstetric and Gynaecologic Pathology. Edinburgh: Churchill Livingstone, 1987:411-56.
26. Shimizu Y, Kamoi S, Amada S, Akiyama F, Silverberg SG. Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up. Cancer 1998; 82:893-901.
27. Shimizu Y, Kamoi S, Amada S, Akiyama F, Hasumi K, Silverberg SG. The grader and the typer should be friends: a study of comparative value of histopathologic grading and typing of ovarian epithelial carcinoma [Abstract]. Mod Palhol 1998;11:115A.
28. Shaw PA, Slingerland JM, Sugimoto A, Covens AL. Prognostic implications of the cell cycle inhibitor p27llpl in ovarian cancer [Abstract]. Mod Palhol 1999;12:124A.
29. Shaw PA, Zweemer RP, McLaughlin J, Narod SA, Risch H, Jacobs IJ. Characteristics of genetically determined ovarian cancer [Abstract]. Mod Palhol 1999;12:124A.